From virtuality to reality - Virtual screening in lead discovery and lead optimization: A medicinal chemistry perspective

被引:1
|
作者
Rester, Ulrich [1 ]
机构
[1] Bayer HealthCare, Global Drug Discovery, Lead Generat & Optimizat, Med Chem, D-42096 Elberfeld, Germany
关键词
drug design; ITC; NMR; virtual screening; x-ray crystallography;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Drug discovery and development is an interdisciplinary, expensive and time-consuming process. Scientific advancements during the past two decades have altered the way pharmaceutical research produces novel bio-active molecules. Advances in computational techniques and hardware solutions have enabled in silico methods, and in particular virtual screening, to speed up modern lead identification and lead optimization. Recent successes have proven the power of combining virtual screening with complementary and synergistic biophysical methods, such as X-ray crystallography, NMR spectroscopy and isothermal titration calorimetry (ITC). This review addresses key issues, challenges and recent improvements of virtual screening methods and strategies. Examples highlighting the impact of an ntegrated virtual screening and biophysical characterization platform in the lead identification and optimization process are presented and discussed.
引用
收藏
页码:559 / 568
页数:10
相关论文
共 50 条
  • [31] Aryltriflates as a Neglected Moiety in Medicinal Chemistry: A Case Study from a Lead Optimization of CXCL8 Inhibitors
    Moriconi, Alessio
    Bigogno, Chiara
    Bianchini, Gianluca
    Caligiuri, Antonio
    Resconi, Anna
    Dondio, Massimo G.
    D'Anniballe, Gaetano
    Allegretti, Marcello
    ACS MEDICINAL CHEMISTRY LETTERS, 2011, 2 (10): : 768 - 773
  • [32] Computational chemistry in drug lead discovery and design
    Cavasotto, Claudio N.
    Gabriela Aucar, Maria
    Adler, Natalia S.
    INTERNATIONAL JOURNAL OF QUANTUM CHEMISTRY, 2019, 119 (02)
  • [33] Fragment-to-Lead Medicinal Chemistry Publications in 2020
    de Esch, Iwan J. P.
    Erlanson, Daniel A.
    Jahnke, Wolfgang
    Johnson, Christopher N.
    Walsh, Louise
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (01) : 84 - 99
  • [34] Fragment-to-Lead Medicinal Chemistry Publications in 2023
    Holvey, Rhian S.
    Erlanson, Daniel A.
    de Esch, Iwan J. P.
    Farkas, Barbara
    Jahnke, Wolfgang
    Nishiyama, Tsuyoshi
    Woodhead, Andrew J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2025, 68 (02) : 986 - 1001
  • [35] Fragment-to-Lead Medicinal Chemistry Publications in 2019
    Jahnke, Wolfgang
    Erlanson, Daniel A.
    de Esch, Iwan J. P.
    Johnson, Christopher N.
    Mortenson, Paul N.
    Ochi, Yuji
    Urushima, Tatsuya
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (24) : 15494 - 15507
  • [36] Fragment-to-Lead Medicinal Chemistry Publications in 2018
    Erlanson, Daniel A.
    de Esch, Iwan J. P.
    Jahnke, Wolfgang
    Johnson, Christopher N.
    Mortenson, Paul N.
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (09) : 4430 - 4444
  • [37] Fragment-to-Lead Medicinal Chemistry Publications in 2017
    Mortenson, Paul N.
    Erlanson, Daniel A.
    de Esch, Iwan J. P.
    Jahnke, Wolfgang
    Johnson, Christopher N.
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (08) : 3857 - 3872
  • [38] Quantum Chemical Approaches in Structure-Based Virtual Screening and Lead Optimization
    Cavasotto, Claudio N.
    Adler, Natalia S.
    Aucar, Maria G.
    FRONTIERS IN CHEMISTRY, 2018, 6
  • [39] Fragment-to-Lead Medicinal Chemistry Publications in 2021
    Walsh, Louise
    Erlanson, Daniel A.
    de Esch, Iwan J. P.
    Jahnke, Wolfgang
    Woodhead, Andrew
    Wren, Ella
    JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (02) : 1137 - 1156
  • [40] Indolizidine Alkaloids: Prospective Lead Molecules in Medicinal Chemistry
    Sharma, Vikas
    Kamal, Raj
    Kumar, Dinesh
    Kumar, Vipan
    CURRENT TRADITIONAL MEDICINE, 2021, 7 (01) : 45 - 56